Skip to main content
Propanc Biopharma, Inc. logo

Propanc Biopharma, Inc. — Investor Relations & Filings

Ticker · PPCB ISIN · US74346N4043 LEI · 549300Q3HY827FNV8Y56 US Professional, scientific and technical activities
Open in API
Filings indexed 412 across all filing types
Latest filing 2015-02-17 Interim / Quarterly Rep…
Country US United States of America
Listing US PPCB

About Propanc Biopharma, Inc.

https://www.propanc.com/

Propanc Biopharma, Inc. is a clinical-stage company developing cancer treatments focused on preventing tumor recurrence and metastasis. Its lead candidate, PRP, is a pancreatic proenzyme formulation designed to target and eradicate cancer stem cells. The therapeutic approach aims to suppress tumor progression by controlling cancer cell migration, inhibiting the formation of tumor blood vessels, and inducing cell death. The company's primary focus is on developing long-term therapies for patients with solid tumors, such as pancreatic cancer.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2015
2015-02-17 English
FORM 4
Director's Dealing
2015-01-13 English
SCHEDULE 13D
Major Shareholding Notification
2015-01-01 English
DEF 14C
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a DEF 14C filing, which is an Information Statement pursuant to Section 14(c) of the Securities Exchange Act of 1934. It informs shareholders of corporate actions taken by written consent of majority stockholders, specifically the approval to amend the Certificate of Incorporation to increase authorized common stock shares. The document explicitly states it is not a proxy solicitation and no meeting will be held. The content focuses on notifying shareholders of the action already approved, consistent with the purpose of a Proxy Solicitation & Information Statement (PSI). It is not an announcement of voting results (DVA), nor a management or board change announcement (MANG), nor a financial report. The document is substantive and not a brief announcement or certification, so it is not RNS or RPA. Therefore, the correct classification is Proxy Solicitation & Information Statement (PSI).
2014-12-18 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes details about unregistered sales of equity securities (Series A Preferred Stock issued to the CEO), amendments to the Certificate of Incorporation (authorizing new preferred stock and increasing authorized common stock), and related exhibits. There are no financial statements or detailed financial performance data presented, nor is this a full annual or quarterly report. The document primarily announces changes in capital structure and corporate governance documents. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to issuance of new shares and amendments affecting capital stock. The document length is over 6000 characters and contains substantive information, so it is not a mere announcement of a report (RPA) or a regulatory filing fallback (RNS).
2014-12-16 English
FORM PRE 14C
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a SEC filing titled 'Schedule 14C Information Statement' pursuant to Section 14(c) of the Securities Exchange Act of 1934. It is an Information Statement notifying shareholders of corporate actions approved by written consent of majority stockholders, specifically an amendment to increase authorized common stock shares. The document explicitly states it is not a proxy solicitation and no shareholder meeting will be held. The filing is an Information Statement under Schedule 14C, which is used to inform shareholders of actions taken without a meeting. This type of filing corresponds to Proxy Solicitation & Information Statement (PSI) filings. The document is lengthy (15,000 characters) and contains detailed information about the corporate action, not just an announcement or a brief notice. Therefore, the correct classification is Proxy Solicitation & Information Statement (PSI).
2014-11-26 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.